Investigation of alpha-phenylnorstatine and alpha-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors
2011 (English)In: Bioorganic & Medicinal Chemistry, ISSN 0968-0896, E-ISSN 1464-3391, Vol. 19, no 1, 145-155 p.Article in journal (Refereed) Published
Inhibition of the BACE-1 protease enzyme has over the recent decade developed into a promising drug strategy for Alzheimer therapy. In this report, more than 20 new BACE-1 protease inhibitors based on alpha-phenylnorstatine, alpha-benzylnorstatine, iso-serine, and beta-alanine moieties have been prepared. The inhibitors were synthesized by applying Fmoc solid phase methodology and evaluated for their inhibitory properties. The most potent inhibitor, tert-alcohol containing (R)-12 (IC(50) = 0.19 mu M) was co-crystallized in the active site of the BACE-1 protease, furnishing a novel binding mode in which the N-terminal amine makes a hydrogen bond to one of the catalytic aspartic acids.
Place, publisher, year, edition, pages
2011. Vol. 19, no 1, 145-155 p.
Alzheimer's disease, BACE-1 inhibitors, tert-Hydroxyl, Transition state mimic, alpha-Phenylnorstatine, alpha-Benzylnorstatine
Organic Chemistry Biochemistry and Molecular Biology Pharmacology and Toxicology
IdentifiersURN: urn:nbn:se:su:diva-68406DOI: 10.1016/j.bmc.2010.11.042ISI: 000285724800014OAI: oai:DiVA.org:su-68406DiVA: diva2:472383
authorCount :92012-01-032012-01-032012-01-03Bibliographically approved